Half Year 2021 Silence Therapeutics PLC Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the Silence Therapeutics Interim Results 2021 Conference Call and Webcast. (Operator Instructions) I will now hand over to Gem Hopkins, Head of IR and Corporate Communications, to open the webinar. Please go ahead, madam.
Good morning, and good afternoon, everyone. Thank you for joining us today. Joining me today on the call are Mark Rothera, our President and CEO, who will provide an update on the business; Dr. Giles Campion, our Head of R&D and Chief Medical Officer, who will provide an update on our clinical programs; and Craig Tooman, our Chief Financial Officer, who will review our financials before opening the call to your questions. For those of you participating via conference call, the accompanying slides can be accessed by going to the Investors section of our corporate website at www.silence-therapeutics.com.
Turning to Slide 2. I'd like to remind you that during today's call, management will make projections
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |